BHIVA 2015: People Who Don't Reveal HIV Status Have as Good Health Outcomes as Those Who Do
- Details
- Category: HIV Disease Progression
- Published on Wednesday, 06 May 2015 00:00
- Written by Roger Pebody
A large survey of people attending HIV clinics in the UK has found that individuals who chose not to disclose their HIV status to other people were no more likely to suffer from depression or anxiety, to have difficulty adhering to antiretroviral therapy (AR), or to have worse HIV outcomes, according to research presented at the British HIV Association (BHIVA) annual meeting last month in Brighton.
BHIVA 2015: Undiagnosed HIV Infections Picked Up When Testing People with Other Medical Conditions
- Details
- Category: HIV Testing & Diagnosis
- Published on Friday, 01 May 2015 00:00
- Written by Roger Pebody
A Europe-wide project offering HIV tests to hospital patients with glandular fever symptoms, swollen lymph nodes, a low white blood cell count, a low platelet count, or pneumonia has found that over 3% of tested patients had previously undiagnosed HIV, according to a presentation at the British HIV Association (BHIVA) annual meeting last month in Brighton. This significantly exceeds the level of 0.1% HIV prevalence at which routine HIV testing interventions are considered to be cost-effective.
BHIVA 2015: HIV Treatment Outcomes No Better with Single-tablet Regimens than Individual Pills
- Details
- Category: Drug Pricing & Patents
- Published on Thursday, 23 April 2015 00:00
- Written by Roger Pebody
One-pill-a-day HIV treatments such as Atripla, Stribild, Complera, and Triumeq and Triumeq have the same rates of virological failure, drug resistance, and side effects as multiple tablet regimens, according to a meta-analysis presented to the British HIV Association (BHIVA) conference this week in Brighton. Single tablets cost the UK National Health Service (NHS) 5 five times more but have unproven clinical benefits, said Andrew Hill of Chelsea and Westminster Hospital.
BHIVA 2015: HIV+ Men on Antiretroviral Treatment Have Undetectable Rectal Viral Load
- Details
- Category: HIV Sexual Transmission
- Published on Monday, 27 April 2015 00:00
- Written by Roger Pebody
A small study assessing the infectiousness of HIV-positive gay men taking antiretroviral therapy has found that all study participants had an undetectable viral load in the rectum, according to a presentation at the British HIV Association (BHIVA) conference last week in Brighton. Men who had rectal gonhorrea or chlamydia did not have detectable virus either, suggesting that concerns about sexually transmitted infections raising the risk of HIV transmission may be unfounded when people are taking effective HIV treatment.
BHIVA 2015: Many People with HIV Willing to Take Part in Cure Research Despite its Risks
- Details
- Category: Search for a Cure
- Published on Thursday, 23 April 2015 00:00
- Written by Roger Pebody
There is a strong interest among people living with HIV in research towards an HIV cure, with many potential participants willing to consider antiretroviral treatment interruption. Respondents to a survey presented at the British HIV Association (BHIVA) conference this week in Brighton generally understood that they would be unlikely to benefit personally from cure research. Priorities for a cure were to eliminate health problems and the risk of HIV transmission, rather than necessarily testing HIV-negative.
Web Design and Development by